Literature DB >> 26443701

The rationale for deep brain stimulation in Alzheimer's disease.

Zaman Mirzadeh1, Ausaf Bari2, Andres M Lozano3.   

Abstract

Alzheimer's disease is a major worldwide health problem with no effective therapy. Deep brain stimulation (DBS) has emerged as a useful therapy for certain movement disorders and is increasingly being investigated for treatment of other neural circuit disorders. Here we review the rationale for investigating DBS as a therapy for Alzheimer's disease. Phase I clinical trials of DBS targeting memory circuits in Alzheimer's disease patients have shown promising results in clinical assessments of cognitive function, neurophysiological tests of cortical glucose metabolism, and neuroanatomical volumetric measurements showing reduced rates of atrophy. These findings have been supported by animal studies, where electrical stimulation of multiple nodes within the memory circuit have shown neuroplasticity through stimulation-enhanced hippocampal neurogenesis and improved performance in memory tasks. The precise mechanisms by which DBS may enhance memory and cognitive functions in Alzheimer's disease patients and the degree of its clinical efficacy continue to be examined in ongoing clinical trials.

Entities:  

Keywords:  Alzheimer’s disease; Cognition; Deep brain stimulation; Dementia; Fornix; Nucleus basalis of Meynert

Mesh:

Year:  2015        PMID: 26443701     DOI: 10.1007/s00702-015-1462-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  55 in total

Review 1.  Deep brain stimulation for the treatment of Alzheimer disease and dementias.

Authors:  Adrian W Laxton; Andres M Lozano
Journal:  World Neurosurg       Date:  2012-06-19       Impact factor: 2.104

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.

Authors:  R C Pearson; M V Sofroniew; A C Cuello; T P Powell; F Eckenstein; M M Esiri; G K Wilcock
Journal:  Brain Res       Date:  1983-12-19       Impact factor: 3.252

5.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

6.  Disease progression meta-analysis model in Alzheimer's disease.

Authors:  Kaori Ito; Sima Ahadieh; Brian Corrigan; Jonathan French; Terence Fullerton; Thomas Tensfeldt
Journal:  Alzheimers Dement       Date:  2009-07-09       Impact factor: 21.566

7.  NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease.

Authors:  G A Higgins; E J Mufson
Journal:  Exp Neurol       Date:  1989-12       Impact factor: 5.330

8.  LTP induction within a narrow critical period of immature stages enhances the survival of newly generated neurons in the adult rat dentate gyrus.

Authors:  Takashi Kitamura; Yoshito Saitoh; Akiko Murayama; Hiroyuki Sugiyama; Kaoru Inokuchi
Journal:  Mol Brain       Date:  2010-04-28       Impact factor: 4.041

9.  The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation.

Authors:  Hiroki Toda; Clement Hamani; Adrian P Fawcett; William D Hutchison; Andres M Lozano
Journal:  J Neurosurg       Date:  2008-01       Impact factor: 5.115

10.  Severe scene learning impairment, but intact recognition memory, after cholinergic depletion of inferotemporal cortex followed by fornix transection.

Authors:  Philip G F Browning; David Gaffan; Paula L Croxson; Mark G Baxter
Journal:  Cereb Cortex       Date:  2009-05-15       Impact factor: 5.357

View more
  14 in total

1.  Multimodal Encoding of Novelty, Reward, and Learning in the Primate Nucleus Basalis of Meynert.

Authors:  Clarissa Martinez-Rubio; Angelique C Paulk; Eric J McDonald; Alik S Widge; Emad N Eskandar
Journal:  J Neurosci       Date:  2018-01-18       Impact factor: 6.167

2.  Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond.

Authors:  Walid Bouthour; Pierre Mégevand; John Donoghue; Christian Lüscher; Niels Birbaumer; Paul Krack
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

Review 3.  Deep Brain Stimulation to Alleviate Freezing of Gait and Cognitive Dysfunction in Parkinson's Disease: Update on Current Research and Future Perspectives.

Authors:  Chuyi Huang; Heling Chu; Yan Zhang; Xiaoping Wang
Journal:  Front Neurosci       Date:  2018-02-16       Impact factor: 4.677

Review 4.  Deep brain stimulation for Alzheimer's Disease: An update.

Authors:  Majed Aldehri; Yasin Temel; Ibrahim Alnaami; Ali Jahanshahi; Sarah Hescham
Journal:  Surg Neurol Int       Date:  2018-03-07

Review 5.  Brain Stimulation in Alzheimer's Disease.

Authors:  Chun-Hung Chang; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Front Psychiatry       Date:  2018-05-22       Impact factor: 4.157

6.  Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments.

Authors:  Martin Jakobs; Anton Fomenko; Andres M Lozano; Karl L Kiening
Journal:  EMBO Mol Med       Date:  2019-04       Impact factor: 12.137

Review 7.  A circuit view of deep brain stimulation in Alzheimer's disease and the possible mechanisms.

Authors:  Danfang Yu; Huanhuan Yan; Jun Zhou; Xiaodan Yang; Youming Lu; Yunyun Han
Journal:  Mol Neurodegener       Date:  2019-08-08       Impact factor: 14.195

Review 8.  The Medial Septum as a Potential Target for Treating Brain Disorders Associated With Oscillopathies.

Authors:  Yuichi Takeuchi; Anett J Nagy; Lívia Barcsai; Qun Li; Masahiro Ohsawa; Kenji Mizuseki; Antal Berényi
Journal:  Front Neural Circuits       Date:  2021-07-08       Impact factor: 3.492

9.  Gamma Band Neural Stimulation in Humans and the Promise of a New Modality to Prevent and Treat Alzheimer's Disease.

Authors:  Barry McDermott; Emily Porter; Diarmaid Hughes; Brian McGinley; Mark Lang; Martin O'Halloran; Marggie Jones
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Effects of optogenetic stimulation of basal forebrain parvalbumin neurons on Alzheimer's disease pathology.

Authors:  Caroline A Wilson; Sarah Fouda; Shuzo Sakata
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.